Current options for the management of postmenopausal osteoporosis - PubMed (original) (raw)

Review

. 2011 Nov;12(16):2533-52.

doi: 10.1517/14656566.2011.618123. Epub 2011 Sep 15.

Affiliations

• PMID: 21916810
• DOI: 10.1517/14656566.2011.618123

Review

Current options for the management of postmenopausal osteoporosis

Marie-Paule Lecart et al. Expert Opin Pharmacother. 2011 Nov.

Abstract

Introduction: Osteoporosis is a well-recognized disease with severe consequences if left untreated. The prevention of osteoporosis-associated fractures should include fall prevention, calcium supplementation and life-style advice, as well as pharmacological therapy using agents with proven antifracture efficacy.

Areas covered: This manuscript offers an evidence-based critical assessment of the currently available efficacy data on all new chemical entities that have been granted a marketing authorization for the management of primary osteoporosis in women.

Expert opinion: The availability of new therapeutic agents makes clinical decision making in osteoporosis more complex. Therapeutic decisions should be based on a balance between the benefits and risks of treatment, which must be carefully considered in each particular case, both by the physician and the patient. Indeed, no single agent is appropriate for all patients. Therefore, treatment decisions should be made on a tailor-made basis, taking into account all measures of treatment effect and risk, before making informed judgments about the best individual treatment option.

PubMed Disclaimer

Similar articles

• New developments in the treatment of osteoporosis.
  Eriksen EF, Halse J, Moen MH. Eriksen EF, et al. Acta Obstet Gynecol Scand. 2013 Jun;92(6):620-36. doi: 10.1111/j.1600-0412.2012.01473.x. Acta Obstet Gynecol Scand. 2013. PMID: 22646526 Review.
• [Osteoporosis].
  Buck G, Perger L, Bischoff-Ferrari HA. Buck G, et al. Praxis (Bern 1994). 2011 Jul 6;100(14):821-32. doi: 10.1024/1661-8157/a000599. Praxis (Bern 1994). 2011. PMID: 21732293 German. No abstract available.
• EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
  Palacios S, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S. Palacios S, et al. Maturitas. 2012 Feb;71(2):194-8. doi: 10.1016/j.maturitas.2011.11.010. Epub 2011 Dec 15. Maturitas. 2012. PMID: 22176952 Review.
• How to manage postmenopausal osteoporosis?
  Body JJ. Body JJ. Acta Clin Belg. 2011 Nov-Dec;66(6):443-7. doi: 10.2143/ACB.66.6.2062612. Acta Clin Belg. 2011. PMID: 22338309 Review.
• Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
  Reginster JY. Reginster JY. Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Drugs. 2011. PMID: 21175240 Review.

Cited by

• The Effects of Cosmos caudatus on Structural Bone Histomorphometry in Ovariectomized Rats.
  Mohamed N, Gwee Sian Khee S, Shuid AN, Muhammad N, Suhaimi F, Othman F, Babji AS, Soelaiman IN. Mohamed N, et al. Evid Based Complement Alternat Med. 2012;2012:817814. doi: 10.1155/2012/817814. Epub 2012 Aug 8. Evid Based Complement Alternat Med. 2012. PMID: 22924056 Free PMC article.
• Assessment of the antiosteoporotic treatment initiation: A retrospective observational study in Greece.
  Rizou S, Aravantinos L, Paganas A, Ballas M, Lyritis GP. Rizou S, et al. J Frailty Sarcopenia Falls. 2017 Dec 1;2(4):78-82. doi: 10.22540/JFSF-02-078. eCollection 2017 Dec. J Frailty Sarcopenia Falls. 2017. PMID: 32300684 Free PMC article.
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
  Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). Kanis JA, et al. Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19. Osteoporos Int. 2013. PMID: 23079689 Free PMC article.
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
  Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). Kanis JA, et al. Osteoporos Int. 2019 Jan;30(1):3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15. Osteoporos Int. 2019. PMID: 30324412 Free PMC article.
• An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis.
  Gu F, Jiang J, Wang S, Feng T, Zhou Y, Ma Y, Shen S. Gu F, et al. Am J Transl Res. 2019 Sep 15;11(9):6032-6039. eCollection 2019. Am J Transl Res. 2019. PMID: 31632571 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Taylor & Francis